Related references
Note: Only part of the references are listed.Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort
Jaime Guzman et al.
JOURNAL OF RHEUMATOLOGY (2017)
Risk of liver disease in methotrexate treated patients
Richard Conway et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
The Pattern of Juvenile Idiopathic Arthritis in a Single Tertiary Center in Saudi Arabia
Mohammad H. Al-Hemairi et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2016)
Propensity-Adjusted Association of Methotrexate With Overall Survival in Rheumatoid Arthritis
Mary Chester M. Wasko et al.
ARTHRITIS AND RHEUMATISM (2013)
Elevated Serum Resistin in Juvenile IdiopathicArthritis: Relation to Categories and Disease Activity
Tamer A. Gheita et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Early predictors of increased bone resorption in juvenile idiopathic arthritis: OPG/RANKL ratio, as a key regulator of bone metabolism
Eman A. M. Alkady et al.
EGYPTIAN RHEUMATOLOGIST (2011)
Effectiveness and Toxicity of Methotrexate in Juvenile Idiopathic Arthritis: Comparison of 2 Initial Dosing Regimens
Mara L. Becker et al.
JOURNAL OF RHEUMATOLOGY (2010)
Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis
W. Katchamart et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis
Kristen Hayward et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis
L Tilling et al.
CLINICAL DRUG INVESTIGATION (2006)
Share Paper
